0001943112-26-000004.txt : 20260204 0001943112-26-000004.hdr.sgml : 20260204 20260204175009 ACCESSION NUMBER: 0001943112-26-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260202 FILED AS OF DATE: 20260204 DATE AS OF CHANGE: 20260204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nelson Jeffrey Edward CENTRAL INDEX KEY: 0001943112 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38899 FILM NUMBER: 26599557 MAIL ADDRESS: STREET 1: C/O MILESTONE PHARMACEUTICALS INC. STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001408443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 BUSINESS PHONE: (514) 336-0444 MAIL ADDRESS: STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 4 1 form4-02042026_050205.xml X0508 4 2026-02-02 0001408443 Milestone Pharmaceuticals Inc. MIST 0001943112 Nelson Jeffrey Edward C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420 MONTREAL A8 H4M 2X6 QUEBEC, CANADA false true false false Chief Operating Officer 0 Employee Stock Option (right to buy) 1.97 2026-02-02 4 A 0 204000 0 A 2036-02-02 Common Shares 204000 204000 D Restricted Stock Unit 2026-02-02 4 A 0 136000 0 A Common Shares 136000 136000 D One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Each restricted stock unit represents a contingent right to receive one common share. One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date. /s/ Joseph Oliveto, Attorney-in-Fact 2026-02-04